X linked mental retardation

Tunisie Medicale

Volumn 87, Issue 5, 2009, Pages 311-318

  Rejeb, Imen ^a   Jemaa, Lamia Ben ^a,b   Chaabouni, Habiba ^a,b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Mental retardation; X linked

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; FRAGILE X MENTAL RETARDATION PROTEIN; FTSJ PROTEIN; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTERLEUKIN 1 RECEPTOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; METHYL CPG BINDING PROTEIN 2; MONOCARBOXYLATE TRANSPORTER 8; NEUROLIGIN; NEUROLIGIN 3; NEUROLIGIN 4; OLIGOPHRENIN 1; P21 ACTIVATED KINASE 3; POLYGLUTAMINE BINDING PROTEIN 1; RAB GDP DISSOCIATION INHIBITOR 1; S6 KINASE; SLC6A8 PROTEIN; SYNAPSIN I; TETRASPANIN; UNCLASSIFIED DRUG; X LINKED HELICASE 2; ZINC FINGER PROTEIN 41;

AGTR2 GENE; ARHGEF6 GENE; ARX GENE; ATRX GENE; AUTISM; CEREBELLAR ATAXIA; CLINICAL FEATURE; COFFIN LOWRY SYNDROME; DLG3 GENE; DYSTONIA; EPILEPSY; FACL4 GENE; FMR2 GENE; FRAGILE X SYNDROME; FTSJ1 GENE; GDI1 GENE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IL1RAPL GENE; INFANTILE SPASM; JARID1C GENE; MECP2 GENE; MICROCEPHALY; NLGN3 GENE; NLGN4 GENE; OPHN1 GENE; PAK3 GENE; PQBP1 GENE; PREVALENCE; RETT SYNDROME; REVIEW; RSK2 GENE; SHORT STATURE; SLC16A2 GENE; SLC6A8 GENE; SPASTIC PARAPLEGIA; SYN1 GENE; TM4SF2 GENE; X LINKED MENTAL RETARDATION; ZNF41 GENE; GENETICS;

HUMANS; MENTAL RETARDATION, X-LINKED;

EID: 73949142864     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. American Association on Mental Retardation. Mental Retardation: Definition, Classification, and Systems of Supports, 10th edn. Washington, 2002.
2. Hamel BCJ. X-linked mental retardation; a clinical and molecular study. PhD Thesis. Nijmegen (webdoc.ubn.-kun.nl/mono/h/hamel-b/xlinmere.pdf)1999.
3. Leonard H, Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002; 8: 117-134.
4. Turner G, Turner B. X-linked mental retardation. J Med Genet 1974; 11: 109-113.
5. Croen LA, Grether JK, Selvin S. The epidemiology of mental retardation of unknown cause. Pediatrics 2001; 107: E86.
6. Kleefstra T, Hamel BCJ. X-linked mental retardation: further lumping, splitting and emerging phenotypes. Clin Genet 2005; 67: 451-467
7. Crawford DC, Acuna JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001; 3: 359-371.
8. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996: 64; 196-197.
9. Fishburn J, Turner G, Daniel A, Brookwell R. The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers. Am J Med Genet 1983; 14: 713-724.
10. Herbst DS, Miller JR. Nonspecific X-linked mental retardation II. the frequency in British Columbia. Am J Med Genet 1980; 7: 461-469.
11. Ropers HH, Hamel BCJ. X-linked mental retardation. Nat Rev Genet 2005; 6: 46-57.
12. Mandel JL, Chelly J. Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations. Eur J Hum Genet 2004; 12: 689-693.
13. Gronskov K, Hjalgrim H, Nielsen IM, Brondum-Nielsen K. Screening of the ARX gene in 682 retarded males. Eur J Hum Genet 2004 ; 12: 701-705.
14. Bienvenu T, Poirier K, Friocourt G et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 2002; 11: 981-991.
15. Rosenberg EH, Almeida LS, Kleefstra T et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 2004; 75: 97-105.
16. Yntema HG, Kleefstra T, Oudakker AR et al. Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 2002; 10: 487-490.
17. Wood T, Rosenberg EH, Clark AJ et al. Molecular and biochemical testing of creatine deficiency in an MR population suggests a 1% prevalence. American Society of Human Genetics, 54th annual meeting, Toronto 2004.
18. Shevell M, Ashwal S, Donley D et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003; 60 :367-80.
19. Knight SJ, Regan R, Nicod A et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999; 354:1676-81.
20. Flint J, Knight S. The use of telomere probes to investigate submicroscopic rearrangements associated with mental retardation. Curr Opin Genet Dev 2003; 13:310-16.
21. Sutherland, G. R.; Baker, E. Characterisation of a new rare fragile site easily confused with the fragile X. Hum Molec Genet 1992; 1: 111-113.
22. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nature Genet 1996 ; 13:105-108.
23. Gu Y, Shen Y, Gibbs RA, Nelson DA. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nature Genet 1996; 13:109-113.
24. Stayton C L, Dabovic B., Gulisano M et al. Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. Hum Molec Genet 1994; 3: 1957-1964.
25. Gibbons R J, Picketts D J, Villard L, Higgs DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 1995; 80: 837-845.
26. Hamel B C J, Kremer H, Wesby-van Swaay E et al. A gene for nonspecific X-linked mental retardation (MRX41) is located in the distal segment of Xq28. Am J Med Genet. 1996; 64: 131-133.
27. D'Adamo P, Menegon A, Lo Nigro C, et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 1998; 19:134-139.
28. Antonarakis SE, Van Aelst L. Mind the GAP, Rho, Rab and GDI. Nat Genet 1998; 19:106-108.
29. Donnelly A J, Partington M W, Ryan A K, Mulley J C. Regional localisation of two non-specific X-linked mental retardation genes (MRX30 and MRX31). Am J Med Genet 1996; 64: 113-120.
30. Allen KM, Gleeson JG, Bagrodia S, et al. PAK3 mutation in nonspecific X-linked mental retardation. Nat Genet 1998 ; 20:25-30.
31. Rejeb I, Saillour Y, Castelnau L, et al. A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features. Eur J Hum Genet 2008; 16:1358-63.
32. Yntema H G, Hamel B C, Smits A P et al. Localisation of a gene for non-specific X linked mental retardation (MRX46) to Xq25-q26. J Med Genet 1998; 35: 801-805.
33. Kutsche K, Yntema H, Brandt A, et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000 ; 26:247-250.
34. Carrié A, Jun L, Bienvenu T, et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999 ; 23:25-31.
35. Zemni R, Bienvenu T, Vinet MC, et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 2000; 24:167-170.
36. Allen KM, Gleeson JG, Bagrodia S et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 1998 ; 20: 25-30.
37. Billuart P, Bienvenu T, Ronce N et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998; 392: 923-926.
38. Okazawa H, Rich T, Chang A et al. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 2002; 34: 701-713.
39. Kalscheuer VM, Freude K, Musante L et al. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet 2003; 35: 313-115.
40. Stromme P, Sundet K, Mork C, Cassiman J-J, Fryns J-P, Claes S. X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11. J Med Genet 1999; 36: 374-378.
41. Stromme P, Mangelsdorf ME, Shaw MA et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002; 30:441-5.
42. Kato M, Das S, Petras K et al. Mutations of ARX are associated with striking pleiotropy and consistent genotypephenotype correlation. Hum Mutat 2004; 23: 147-159.
43. Partington MW, Mulley JC, Sutherland GR, Hockey A, Thode A, Turner G. X-linked mental retardation with dystonic movements of the hands. Am J Med Genet 1988; 30: 251-262.
44. Frints SG, Froyen G, Marynen P, Willekens D, Legius E, Fryns JP. Re-evaluation of MRX36 family after discovery of an ARX gene mutation reveals mild neurological features of Partington syndrome. Am J Med Genet 2002; 112: 427-428.
45. Bienvenu T, Poirier K. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation.Hum Mol Genet 2002; 11:981-991.
46. Merienne K, Jacquot S, Pannetier S et al. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. (Letter) Nat Genet 1999; 22; 13-14.
47. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Euro J Paediatr Neurol 2002; 6: 293-297.
48. Mnatzakanian GN, Lohi H, Munteanu I et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004; 36: 339-341.
49. Amir RE, Van den Veyver IB, WanM, Tran CQ, FranckeU, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188.
50. Kutsche K, Yntema H, Brandt A et al. Mutations in ARHGEF6, encoding a guanine nucleotide exhange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000; 26: 247-250.
51. Claes S, Devriendt K ,Van Goethem G et al. Novel syndromic form of X-linked complicated spastic paraplegia. Am J Med Genet 2000; 94: 1-4.
52. Jensen LR, Amende M, Gurok U et al. Mutations in the JARID1C Gene, Which Is Involved in Transcriptional Regulation and Chromatin Remodeling, Cause X-Linked Mental Retardation. Am J Hum Genet 2004; 76: 227-236.
53. Clissold PM, Ponting CP. JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci 2001; 26: 7-9.
54. Raynaud, M.; Moizard, M.-P.; Dessay, B.et al. Systematic analysis of X-inactivation in 19 XLMR families: extremely skewed profiles in carriers in three families. Euro J Hum Genet 2000; 8: 253-258.
55. Meloni I, Muscettola M, Raynaud Met al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 2002; 30: 436-440.
56. Salomons GS, van Dooren S. J. M., Verhoeven, N. M.et al. Xlinked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001; 68: 1497-1500.
57. Salomons GS, van Dooren SJ, Verhoeven NM et al. X-linked creatine transporter defect: an overview. J Inherit Metab Dis 2003; 26: 309-318.
58. Vervoort V S, Beachem M A, Edwards P S et al. AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401-2403.
59. Shoichet S A, Hoffmann K, Menzel C et al. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am J Hum Genet 2003; 73: 1341-1354.
60. Freude K, Hoffmann K, Jensen L-R et al. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet 2004; 75: 305-309.
61. Hamel B C J, Smits A P T, van den Helm B et al. Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis. Am J Med Genet 1999; 85: 290-304.
62. Tarpey P, Parnau J, Blow M et al. Mutations in the DLG3 gene cause non-syndromic X-linked mental retardation. Am J Hum Genet 2004; 75: 318-324.
63. Laumonnier F, Bonnet-Brilhault F, Gomot M et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552-557.
64. Philibert R A, Winfield S L, Sandhu H K, Martin B M, Ginns E I. The structure and expression of the human neuroligin-3 gene. Gene 2000; 246: 303-310.
65. Jamain S, Quach H, Betancur C et al. Paris Autism Research International Sibpair Study: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29.
66. Garcia C C, Blair H J, Seager M et al. Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet 2004; 41: 183-187.
67. Friesema E C H, Grueters A, Biebermann H et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004; 364: 1435-1437.
68. Chiurazzi P, Neri G, Oostra BA. Understanding the biological underpinnings of fragile X syndrome. Curr Opin Pediatr 2003; 15: 559-566.
69. Willemsen R, Oostra BA, Bassell GJ, Dictenberg J. The fragile X syndrome: from molecular genetics to neurobiology. Ment Retard Dev Disabil Res Rev 2004; 10: 60-67.
70. Richards BW, Sylvester PE, Brooker C. Fragile X-linked mental retardation: the Martin-Bell syndrome. J Ment Defic Res 1981; 25 (Pt 4): 253-256.